Are Wall Street Analysts Bullish on Quest Diagnostics Stock?
Company Performance: Quest Diagnostics (DGX) has outperformed the S&P 500 and SPDR S&P Health Care Services ETF over the past year, with a 35.9% increase in stock value compared to the broader market's 20.7% rise, driven by consistent demand, innovation, and strategic acquisitions.
Analyst Ratings and Expectations: Analysts maintain a "Moderate Buy" consensus on DGX stock, with an adjusted EPS forecast of $9.70 for fiscal 2025, and Mizuho Financial has raised its price target to $178, indicating potential upside from current levels.
Trade with 70% Backtested Accuracy
Analyst Views on MFG
About MFG
About the author


SoFi Technologies and Muddy Waters Research: The conflict between SoFi Technologies and Muddy Waters Research intensified over the weekend.
Accounting Practices Concerns: Muddy Waters accused SoFi of not responding to inquiries regarding its accounting practices prior to the release of a short report.
- Hilda Applbaum's Passion: Hilda Applbaum, a resident of Oakland, California, takes great pride in her blueberry bushes.
- Gardening Joy: She enjoys the process of planting seedlings, nurturing their growth, and harvesting the berries for her morning yogurt.
Impact of War on Farming: The ongoing conflict in the Middle East has created significant challenges for farmers in the region.
Investment Opportunities: Despite the difficulties faced by farmers, there is a notable increase in the value of certain farming stocks, presenting potential investment opportunities.
- Stock Performance: Expedia Group shares surged 13.69% during regular trading on Thursday, closing at $251.54, and further increased by 0.11% in after-hours trading to $251.81, reflecting strong market confidence in its growth prospects.
- Insider Trading: Chief Legal Officer Robert Dzielak sold 8,225 shares on Wednesday at a weighted average price of $220.82, totaling approximately $1.82 million, indicating executive confidence and liquidity management within the company.
- Market Capitalization: Expedia's market cap reached $30.82 billion, with a 52-week high of $303.80 and a low of $130.01, demonstrating a robust 31.70% increase in stock price over the past year, highlighting strong market performance.
- Technical Analysis: The current Relative Strength Index (RSI) stands at 60.05, indicating an upward trend, with the stock trading roughly 70% above its 52-week low, showcasing strong momentum as it approaches the upper end of its annual range.
- Stock Decline: Quantum computing company Rigetti Computing (NASDAQ: RGTI) saw its shares tumble 6.6% on Friday, primarily due to unexpected high inflation data and a price target cut on rival D-Wave Quantum, indicating market uncertainty regarding its future profitability.
- Inflation Data Impact: The January Producer Price Index (PPI) revealed core wholesale prices surged 0.8%, nearly tripling the economists' forecast of 0.3%, suggesting the Federal Reserve may delay rate cuts, further negatively impacting speculative stocks like Rigetti's.
- Increased Competitive Pressure: Mizuho analysts slashed D-Wave's price target from $46 to $40, intensifying pressure across the quantum computing sector as investors tend to link the fates of these companies, raising concerns about Rigetti's market position.
- Investor Confidence Wanes: Rigetti's current valuation reflects enormous expectations for future success, yet analysts caution that such success is far from guaranteed, advising investors to be cautious until the valuation aligns more closely with reality.
- Stock Decline: Shares of quantum computing firm Rigetti Computing fell 6.6% on Friday, closing at $17.52, with a market cap now at $6.2 billion, indicating increasing investor uncertainty regarding future profitability.
- Inflation Data Impact: The producer price index (PPI) released on Friday showed core wholesale prices surged 0.8% in January, nearly tripling economists' forecasts, suggesting the Federal Reserve may delay interest rate cuts, negatively impacting speculative stocks like Rigetti.
- Peer Price Cut: Analysts at Mizuho slashed the price target for D-Wave Quantum from $46 to $40, and as a close competitor to Rigetti, this news further heightened investor concerns about the quantum computing sector.
- Investor Confidence Wanes: While quantum computing holds the potential to transform industries, Rigetti's valuation reflects enormous expectations for future success that are far from guaranteed, leading analysts to advise against investment until valuations align more closely with reality.









